Allogeneic Hematopoietic Stem Cell Transplantation Following CAR T Therapy in Relapsed/Refractory Acute Lymphoblastic Leukemia

被引：0
|
作者：
Rafaeli, Natalie [1 ]
Marin, David [2 ]
Ledesma, Celina [2 ]
Jain, Nitin [3 ]
Tewari, Priti [4 ]
Khouri, Issa F. [2 ]
Olson, Amanda L. [5 ]
Alatrash, Gheath [6 ]
Short, Nicholas J. [3 ]
Jabbour, Elias [5 ]
Rezvani, Katy [2 ]
Alousi, Amin M. [2 ]
Popat, Uday [2 ]
Champlin, Richard E. [2 ]
Shpall, Elizabeth J. [2 ]
Kebriaei, Partow [1 ]
机构：
[1] MD Anderson Canc Ctr, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr Houston, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr Houston, Dept Leukemia, Houston, TX USA
[4] Univ Texas MD Anderson Canc Ctr Houston, Dept Pediat Pediat Stem Cell Transplantat & Cellul, Houston, TX USA
[5] Univ Texas MD Anderson Canc Ctr Houston, Houston, TX USA
[6] MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-193954
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2810 / 2811
页数：2
相关论文
共 50 条
  • [41] Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Acute Myeloid Leukemia: A Single Center Analysis
    Deschamps, Paul
    Bulabois, Claude-Eric
    Carre, Martin
    Thiebaut-Bertrand, Anne
    Cahn, Jean-Yves
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 208 - 209
  • [42] IMPACT OF DISEASE STATUS ON OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH REFRACTORY AND RELAPSED ACUTE LYMPHOBLASTIC LEUKEMI
    Cao, J.
    Zhu, X.
    Sun, A.
    Qiu, H.
    Jin, Z.
    Miao, M.
    Wu, D.
    Tang, X.
    HAEMATOLOGICA, 2017, 102 : 662 - 662
  • [43] DONOR-DERIVED CAR-T CELLS FOR THE TREATMENT OF RELAPSED ACUTE B-LYMPHOBLASTIC LEUKEMIA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Deng, Lei
    Yu, Xiaolin
    Song, Xiaocheng
    Guan, Rui
    Shao, Yan
    Li, Wenjun
    Zhou, Fang
    BONE MARROW TRANSPLANTATION, 2024, 59 : 47 - 48
  • [44] Therapeutic strategies, including allogeneic stem cell transplantation, to overcome relapsed/refractory adult T-cell acute lymphoblastic leukemia
    Baek, Dong Won
    Lee, Jung Min
    Kim, Juhyung
    Cho, Hee Jeong
    Moon, Joon Ho
    Sohn, Sang Kyun
    EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (08) : 765 - 775
  • [45] Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Acute Lymphoblastic Leukemia
    Hamilton, Betty Ky
    Rybicki, Lisa
    Abounader, Donna
    Adekola, Kehinde
    Advani, Anjali
    Aldoss, Ibrahim
    Bachanova, Veronika
    Bashey, Asad
    Brown, Stacey
    DeLima, Marcos
    Devine, Steven
    Flowers, Christopher R.
    Ganguly, Siddharth
    Jagasia, Madan
    Kennedy, Vanessa E.
    Kim, Dennis Dong Hwan
    McGuirk, Joseph
    Pullarkat, Vinod
    Romee, Rizwan
    Sandhu, Karamjeet
    Smith, Melody
    Ueda, Masumi
    Viswabandya, Auro
    Khoan Vu
    Wall, Sarah
    Zeichner, Simon B.
    Perales, Miguel -Angel
    Majhail, Navneet S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (07) : 1117 - 1121
  • [46] CAR-T Cell Therapy for Acute Lymphoblastic Leukemia: Transforming the Treatment of Relapsed and Refractory Disease
    Pehlivan, Katherine C.
    Duncan, Brynn B.
    Lee, Daniel W.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2018, 13 (05) : 396 - 406
  • [47] CAR-T Cell Therapy for Acute Lymphoblastic Leukemia: Transforming the Treatment of Relapsed and Refractory Disease
    Katherine C. Pehlivan
    Brynn B. Duncan
    Daniel W. Lee
    Current Hematologic Malignancy Reports, 2018, 13 : 396 - 406
  • [48] Impact of Allogeneic Hematopoietic Cell Transplantation (HCT) As Consolidation Following CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy for Treatment of Relapsed Acute Lymphoblastic Leukemia (ALL)
    Park, Jae H.
    Nikiforow, Sarah
    Kim, Soyoung
    Hu, Zhen-Huan
    Moskop, Amy
    Ahmed, Sairah
    Abid, Muhammad Bilal
    Badar, Talha
    Bredeson, Christopher
    Brown, Valerie
    Cairo, Mitchell S.
    Diaz, Miguel
    Dholaria, Bhagirathbhai
    Ganguly, Siddhartha
    Grover, Natalie S.
    Hanna, Rabi
    Hematti, Peiman
    Kohorst, Mira A.
    Lazarus, Hillard
    Lekakis, Lazaros J.
    Locke, Frederick L.
    Murthy, Hemant S.
    Mussetti, Alberto
    Pulsipher, Michael A.
    Qayed, Muna
    Reshef, Ran
    Rizzieri, David A.
    Salas, Maria Queralt
    Savani, Bipin B.
    Sharma, Akshay
    Schultz, Kirk R.
    Thakar, Monica
    Turtle, Cameron
    Yared, Jean A.
    Wagner, John L.
    Qiu, Xianmiao
    Pasquini, Marcelo C.
    Perales, Miguel-Angel
    BLOOD, 2021, 138
  • [49] Hematopoietic Stem Cell Transplantation Following Unsuccessful Salvage Treatment for Relapsed Acute Lymphoblastic Leukemia in Children
    Inagaki, Jiro
    Fukano, Reiji
    Noguchi, Maiko
    Kurauchi, Koichiro
    Tanioka, Shinji
    Okamura, Jun
    PEDIATRIC BLOOD & CANCER, 2015, 62 (04) : 674 - 679
  • [50] Outcomes of Allogeneic Stem Cell Transplantation after Inotuzumab Ozogamicin Treatment for Relapsed or Refractory Acute Lymphoblastic Leukemia
    Marks, David, I
    Kebriaei, Partow
    Stelljes, Matthias
    Goekbuget, Nicola
    Kantarjian, Hagop
    Advani, Anjali S.
    Merchant, Akil
    Stock, Wendy
    Cassaday, Ryan D.
    Wang, Tao
    Zhang, Hui
    Loberiza, Fausto
    Vandendries, Erik
    DeAngelo, Daniel J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (09) : 1720 - 1729
12345